Global Coronary Artery Bypass Grafts Market Size, Share, and Industry Analysis – by Method, by Surgical Procedure, by Age Group, and by End-use- Growth and Trend Forecast, 2026 -2035
The coronary artery bypass grafts market was projected to reach USD 20.0 billion in 2025. The market is expected to expand at a compound annual growth rate (CAGR) of 3.6%, from USD 20.6 billion in 2026 to USD 28.3 billion by 2035. The rising incidence of coronary artery disease and the growing need for cardiac surgery are driving the market. The growing ageing population and advancements in surgical techniques are also supporting market growth.
Market Overview
According to clinical data published in the Cleveland Clinic Journal of Medicine, about 200,000 CABG procedures are carried out in the US each year, underscoring the ongoing reliance on bypass grafting for complicated coronary artery disease.
The coronary artery bypass grafts (CABG) market has grown steadily over the past decade due to the growing use of advanced surgical methods and ongoing advancements in the infrastructure for cardiac care and graft materials. The trend toward robotically aided and minimally invasive CABG procedures has improved patient outcomes, decreased recuperation time, and increased surgical precision. For instance, LivaNova's Essenz Perfusion System, a modern heart-lung device with integrated monitoring capabilities, was approved by regulators in 2023, facilitating the use of next-generation CABG technologies and enabling safer and more accurate bypass treatments.
The coronary artery bypass grafts (CABG) market is anticipated to develop steadily throughout the course of the projected period due to the advancement of hybrid revascularisation techniques and increased surgical accuracy. For example, Medtronic is anticipated to increase the use of its innovative cardiac surgery solutions, such as the Octopus Stabilisation System, in 2030 to facilitate off-pump and minimally invasive CABG procedures, improving surgical accuracy and shortening recovery times for bypass surgery patients.
Coronary Artery Bypass Grafts Market Overview
Base Year Market Size (2025): USD 20.0 Billion
CAGR: 3.6%
Forecast Year Market Size (2035): USD 28.3 Billion
Leading Region: North America
Emerging Countries: India, Brazil, China, Mexico and South Africa
Major Players:
Medline Industries
3M
Cardinal Health
Kimberly‑Clark Corporation
Mölnlycke Health Care
Coronary Artery Bypass Grafts Market Trends
The global coronary artery bypass grafts (CABG) market is evolving with advancements in surgical techniques, cardiac technologies, and patient-centred treatment approaches.
· The growing use of off-pump and minimally invasive CABG procedures is changing the industry since new methods shorten recovery times and minimise surgical stress and problems.
· Robotic-assisted cardiac surgeries are gaining traction, facilitating more accurate, complex bypass surgeries, fewer incisions, and better clinical results.
· Increased use of hybrid revascularisation techniques, which combine percutaneous coronary interventions (PCI) with CABG, is offering patients more adaptable and efficient therapy options.
· Moreover, enhancements in imaging technologies and perioperative care are increasing bypass surgery success rates, patient monitoring, and surgical planning.
Collectively, these trends are expected to enhance surgical outcomes, reduce recovery times, and support the continued growth of the CABG market worldwide.
Coronary Artery Bypass Grafts Market Analysis
By Method
Off-pump CABG enables effective coronary revascularization while avoiding the use of a heart-lung machine, reducing complications and improving recovery outcomes.
Based on method, the coronary artery bypass grafts market is segmented into off-pump, on-pump, and minimally invasive direct CABG (MIDCAB). The off-pump segment accounted for the largest revenue share of 63.40% in 2025.
By Surgical Procedure
Triple CABG surgery enables comprehensive revascularization by restoring blood flow to multiple blocked coronary arteries, improving cardiac function and patient outcomes.
Based on surgical procedure, the coronary artery bypass grafts market is categorized into single, double, triple, quadruple, and quintuple bypass surgery. The triple CABG surgery segment accounted for the largest revenue share in 2025.
By Age Group
The 55–69 years age group represents the highest incidence of coronary artery disease, making it a key segment for CABG procedures
Based on age group, the coronary artery bypass grafts market is segmented into <40 years, 40–54 years, 55–69 years, and 70 years and above. The 55–69 years segment held the highest share of the market in 2025.
By End-use
Hospitals provide a comprehensive cardiac care infrastructure and advanced surgical capabilities for performing complex CABG procedures
Based on end-use, the coronary artery bypass grafts market is segmented into hospitals, cardiology centres, and others. The hospitals segment dominated the market with the largest revenue share in 2025.
Regional Analysis
North America benefits from advanced cardiac care systems and widespread adoption of complex CABG procedures.
North America dominated the coronary artery bypass grafts market with the highest revenue share of 50.91% in 2025.
Europe is gaining traction with a growing emphasis on cutting-edge cardiac treatments and contemporary surgical techniques.
Europe is anticipated to have significant growth throughout the forecast period, bolstered by an increase in the prevalence of cardiovascular illness, better access to cardiac surgeries, and an increase in the use of minimally invasive CABG procedures.
Key Companies Profiled
The market's competitive environment for coronary artery bypass grafts (CABG) is characterized by strong competition between leading manufacturers of cardiovascular devices and emerging innovators. Prominent corporations, including Medtronic, Boston Scientific, Abbott Laboratories, Terumo Corporation, and Edwards Lifesciences, together own a substantial portion of the global market. Advanced cardiac surgery technology, a wealth of clinical experience, and ongoing investments in minimally invasive and robotically assisted surgical solutions all contribute to their significant position.
Additionally, market players are concentrating on broadening their portfolios of cardiac devices and enhancing surgical results via innovation. For instance, Abbott Laboratories bolstered its cardiovascular portfolio in 2022 by strategically advancing heart care technologies to provide improved treatment strategies for difficult coronary disorders.
Coronary Artery Bypass Grafts Market Companies:
Advancements and strategic expansion in the coronary artery bypass grafts market are being driven by the following notable players:
Abbott Laboratories
B. Braun SE
Boston Scientific
Edwards Lifesciences
Genesee BioMedical
Getinge AB
LivaNova
Medtronic
Terumo Corporation
Transonic Systems
Vascular Graft Solutions
Market Segmentation
This study provides revenue growth and emerging trends across global, regional, and country levels from 2021 to 2035, segmenting the coronary artery bypass grafts market by-
Method (Revenue in USD Million, 2021 - 2035)
Off-pump
On-pump
Minimally Invasive Direct CABG (MIDCAB)
Surgical Procedure (Revenue in USD Million, 2021 - 2035)
Single CABG Surgery
Double CABG Surgery
Triple CABG Surgery
Quadruple CABG Surgery
Quintuple Bypass
Age Group (Revenue in USD Million, 2021 – 2035)
<40 years
40–54 years
55–69 years
70 years and above
End-use (Revenue in USD Million, 2021 – 2035)
Hospitals
Cardiology Centers
Others
Regional (Revenue in USD Million, 2021 - 2035)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Switzerland
Netherlands
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Indonesia
Latin America
Brazil
Mexico
Argentina
Colombia
Middle East and Africa
South Africa
Saudi Arabia
UAE
Kuwait
Table of Content
1. Methodology and Scope
1.1. Scope of the Study
1.1.1. Market Segmentation
1.1.2. Market Definition
1.1.3. Inclusions and Exclusions of the Study
1.2. Research Design
1.2.1. Base Year, Historical Data, and Forecast Period
1.2.2. Data Collection Methods
1.2.2.1. Secondary Sources
1.2.2.2. Primary Sources
1.2.3. Research Methodology
1.2.3.1. Base Year Calculation/ Parent Market Analysis, Company/ Brand Share Analysis, 2025 (Top-down Approach)
1.2.3.2. Volume-Price Approach (Bottom-up Approach)
1.2.3.3. Data Triangulation
1.2.4. Forecasting Model
1.3. Research Assumptions
1.4. Validation and Data Quality Control
1.5. List of Primary Sources
1.6. List of Secondary Sources
2. Executive Summary
2.1. Market Overview
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
3. Industry Outlook
3.1. Industry Ecosystem Analysis
3.2. Parent/ Ancillary Market Analysis
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Restraints/ Challenges
3.3.3. Opportunities
3.4. Consumer Behaviour Analysis
3.5. Value Chain Analysis
3.6. Technology Roadmap
3.7. Porters Analysis
3.8. PESTLE Analysis
4. Market Estimates and Forecasts, By Method, 2021 - 2035 (Market Size in USD Mn, Volume in Absolute Number)
4.1. Off-pump
4.2. On-pump
4.3. Minimally Invasive Direct CABG (MIDCAB)
5. Market Estimates and Forecasts, By Surgical Procedure, 2021 – 2035 (USD Mn)
5.1. Single CABG Surgery
5.2. Double CABG Surgery
5.3. Triple CABG Surgery
5.4. Quadruple CABG Surgery
5.5. Quintuple Bypass
6. Market Estimates and Forecasts, By Age Group, 2021 – 2035 (USD Mn)
6.1. <40 years
6.2. 40–54 years
6.3. 55–69 years
6.4. 70 years and above
7. Market Estimates and Forecasts, By End-use, 2021 – 2035 (USD Mn)
7.1. Hospitals
7.2. Cardiology Centers
7.3. Others
8. Market Estimates and Forecasts, By Region, 2021 - 2035 (USD Mn)
8.1. North America
8.1.1. U.S.
8.1.1.1. U.S. Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.1.1.2. Market Dynamics
8.1.1.3. Competitive Landscape
8.1.1.4. Regulatory Framework
8.1.1.5. Reimbursement Scenario
8.1.2. Canada
8.1.2.1. Canada Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.1.2.2. Market Dynamics
8.1.2.3. Competitive Landscape
8.1.2.4. Regulatory Framework
8.1.2.5. Reimbursement Scenario
8.2. Europe
8.2.1. Germany
8.2.1.1. Germany Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.2.1.2. Market Dynamics
8.2.1.3. Competitive Landscape
8.2.1.4. Regulatory Framework
8.2.1.5. Reimbursement Scenario
8.2.2.
8.2.3. U.K.
8.2.3.1. UK Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.2.3.2. Market Dynamics
8.2.3.3. Competitive Landscape
8.2.3.4. Regulatory Framework
8.2.3.5. Reimbursement Scenario
8.2.4. France
8.2.4.1. France Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.2.4.2. Market Dynamics
8.2.4.3. Competitive Landscape
8.2.4.4. Regulatory Framework
8.2.4.5. Reimbursement Scenario
8.2.5. Italy
8.2.5.1. Italy Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.2.5.2. Market Dynamics
8.2.5.3. Competitive Landscape
8.2.5.4. Regulatory Framework
8.2.5.5. Reimbursement Scenario
8.2.6. Spain
8.2.6.1. Spain Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.2.6.2. Market Dynamics
8.2.6.3. Competitive Landscape
8.2.6.4. Regulatory Framework
8.2.6.5. Reimbursement Scenario
8.2.7. Sweden
8.2.7.1. Sweden Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.2.7.2. Market Dynamics
8.2.7.3. Competitive Landscape
8.2.7.4. Regulatory Framework
8.2.7.5. Reimbursement Scenario
8.2.8. Norway
8.2.8.1. Norway Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.2.8.2. Market Dynamics
8.2.8.3. Competitive Landscape
8.2.8.4. Regulatory Framework
8.2.8.5. Reimbursement Scenario
8.2.9. Denmark
8.2.9.1. Denmark Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.2.9.2. Market Dynamics
8.2.9.3. Competitive Landscape
8.2.9.4. Regulatory Framework
8.2.9.5. Reimbursement Scenario
8.2.10. Switzerland
8.2.10.1. Switzerland Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.2.10.2. Market Dynamics
8.2.10.3. Competitive Landscape
8.2.10.4. Regulatory Framework
8.2.10.5. Reimbursement Scenario
8.2.11. Netherlands
8.2.11.1. Netherlands Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.2.11.2. Market Dynamics
8.2.11.3. Competitive Landscape
8.2.11.4. Regulatory Framework
8.2.11.5. Reimbursement Scenario
8.2.12. Rest of Europe
8.2.12.1. Rest of Europe Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.2.12.2. Market Dynamics
8.2.12.3. Competitive Landscape
8.2.12.4. Regulatory Framework
8.2.12.5. Reimbursement Scenario
8.3. Asia Pacific
8.3.1. China
8.3.1.1. China Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.3.1.2. Market Dynamics
8.3.1.3. Competitive Landscape
8.3.1.4. Regulatory Framework
8.3.1.5. Reimbursement Scenario
8.3.2. Japan
8.3.2.1. Japan Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.3.2.2. Market Dynamics
8.3.2.3. Competitive Landscape
8.3.2.4. Regulatory Framework
8.3.2.5. Reimbursement Scenario
8.3.3. India
8.3.3.1. India Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.3.3.2. Market Dynamics
8.3.3.3. Competitive Landscape
8.3.3.4. Regulatory Framework
8.3.3.5. Reimbursement Scenario
8.3.4. Australia
8.3.4.1. Australia Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.3.4.2. Market Dynamics
8.3.4.3. Competitive Landscape
8.3.4.4. Regulatory Framework
8.3.4.5. Reimbursement Scenario
8.3.5. South Korea
8.3.5.1. South Korea Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.3.5.2. Market Dynamics
8.3.5.3. Competitive Landscape
8.3.5.4. Regulatory Framework
8.3.5.5. Reimbursement Scenario
8.3.6. Thailand
8.3.6.1. Thailand Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.3.6.2. Market Dynamics
8.3.6.3. Competitive Landscape
8.3.6.4. Regulatory Framework
8.3.6.5. Reimbursement Scenario
8.3.7. Indonesia
8.3.7.1. Indonesia Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.3.7.2. Market Dynamics
8.3.7.3. Competitive Landscape
8.3.7.4. Regulatory Framework
8.3.7.5. Reimbursement Scenario
8.3.8. Rest of Asia Pacific
8.3.8.1. Rest of Asia Pacific Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.3.8.2. Market Dynamics
8.3.8.3. Competitive Landscape
8.3.8.4. Regulatory Framework
8.3.8.5. Reimbursement Scenario
8.4. Latin America
8.4.1. Brazil
8.4.1.1. Brazil Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.4.1.2. Market Dynamics
8.4.1.3. Competitive Landscape
8.4.1.4. Regulatory Framework
8.4.1.5. Reimbursement Scenario
8.4.2. Mexico
8.4.2.1. Mexico Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.4.2.2. Market Dynamics
8.4.2.3. Competitive Landscape
8.4.2.4. Regulatory Framework
8.4.2.5. Reimbursement Scenario
8.4.3. Argentina
8.4.3.1. Argentina Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.4.3.2. Market Dynamics
8.4.3.3. Competitive Landscape
8.4.3.4. Regulatory Framework
8.4.3.5. Reimbursement Scenario
8.4.4. Colombia
8.4.4.1. Colombia Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.4.4.2. Market Dynamics
8.4.4.3. Competitive Landscape
8.4.4.4. Regulatory Framework
8.4.4.5. Reimbursement Scenario
8.5. Middle East and Africa
8.5.1. South Africa
8.5.1.1. South Africa Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.5.1.2. Market Dynamics
8.5.1.3. Competitive Landscape
8.5.1.4. Regulatory Framework
8.5.1.5. Reimbursement Scenario
8.5.2. Saudi Arabia
8.5.2.1. Saudi Arabia Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.5.2.2. Market Dynamics
8.5.2.3. Competitive Landscape
8.5.2.4. Regulatory Framework
8.5.2.5. Reimbursement Scenario
8.5.3. UAE
8.5.3.1. UAE Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.5.3.2. Market Dynamics
8.5.3.3. Competitive Landscape
8.5.3.4. Regulatory Framework
8.5.3.5. Reimbursement Scenario
8.5.4. Kuwait
8.5.4.1. Kuwait Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.5.4.2. Market Dynamics
8.5.4.3. Competitive Landscape
8.5.4.4. Regulatory Framework
8.5.4.5. Reimbursement Scenario
8.5.5. Rest of Middle East and Africa
8.5.5.1. Rest of MEA Coronary Artery Bypass Grafts Market Estimates and Forecasts to 2035 (USD Mn)
8.5.5.2. Market Dynamics
8.5.5.3. Competitive Landscape
8.5.5.4. Regulatory Framework
8.5.5.5. Reimbursement Scenario
9. Competitive Landscape
9.1. Company Market Share Analysis, 2024
9.2. Company Tier Structure
9.3. List of Major Suppliers, By Key Countries
9.4. Key Company Positioning Analysis
9.5. Company Profile
9.5.1. Abbott Laboratories
9.5.2. B. Braun SE
9.5.3. Boston Scientific
9.5.4. Edwards Lifesciences
9.5.5. Genesee BioMedical
9.5.6. Getinge AB
9.5.7. LivaNova
9.5.8. Medtronic
9.5.9. Terumo Corporation
9.5.10. Transonic Systems
9.5.11. Vascular Graft Solutions
9.6. Key Development Strategies
9.6.1. New Product Launches
9.6.2. Mergers and Acquisition
9.6.3. Partnerships and Collaborations
9.6.4. Expansion Plans
10. Analyst Perspective
11. Related Reports
Related Research
Global Hyaluronic Acid-Based Dermal Fillers Market Size, Share, and Industry Analysis- by Product Type, by Gender, by Elasticity Module, by Application, and by End-use, Growth and Trend Forecast, 2026 – 2035
Global Non-invasive Fat Reduction Market Size, Share, and Industry Forecast – by Product Type, by Application, by Gender, and by End-use- Growth and Forecast, 2026- 2035
Global Wound Care Market Size, Share, and Industry Analysis – by Product Type, by Wound Type, and by End-use – Growth and Trend Forecast, 2026 -2035
Revolution Insights Briefs
Stay informed with updates on related market reports and key industry topics.